Koji Tokoyoda

Title: Koji Tokoyoda: Innovator in Inflammatory Disease Treatment

Introduction

Koji Tokoyoda is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases. With a total of 2 patents, his work focuses on innovative methods that target specific proteins involved in inflammatory responses.

Latest Patents

Tokoyoda's latest patents include a method for identifying a compound useful with myosin regulatory light chain polypeptide antibody for the treatment of an inflammatory disease. This invention provides a means for inhibiting the function of CD69, which allows for the suppression of inflammatory responses. The composition for treating an inflammatory disease includes an antibody that specifically recognizes a myosin regulatory light chain polypeptide, preferably Myl9, Myl12a, and Myl12b. This invention also outlines methods for treating inflammatory diseases by administering a therapeutically effective amount of the antibody to diagnosed subjects.

Career Highlights

Koji Tokoyoda is affiliated with Chiba University, where he conducts his research and development. His work has been instrumental in advancing the understanding of inflammatory diseases and their treatment options.

Collaborations

Tokoyoda collaborates with notable colleagues, including Toshinori Nakayama and Hiroyuki Hosokawa. Their combined expertise contributes to the innovative research being conducted at Chiba University.

Conclusion

Koji Tokoyoda's contributions to the field of inflammatory disease treatment through his innovative patents highlight his role as a key inventor in medical research. His work continues to pave the way for new therapeutic approaches to managing inflammatory conditions.